Logo image of HLMN

HILLMAN SOLUTIONS CORP (HLMN) Stock Fundamental Analysis

NASDAQ:HLMN - Nasdaq - US4316361090 - Common Stock - Currency: USD

7.77  -0.18 (-2.26%)

After market: 7.77 0 (0%)

Fundamental Rating

4

HLMN gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 128 industry peers in the Machinery industry. There are concerns on the financial health of HLMN while its profitability can be described as average. HLMN is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

HLMN had positive earnings in the past year.
In the past year HLMN had a positive cash flow from operations.
In the past 5 years HLMN reported 4 times negative net income.
Of the past 5 years HLMN 4 years had a positive operating cash flow.
HLMN Yearly Net Income VS EBIT VS OCF VS FCFHLMN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

HLMN has a Return On Assets of 0.79%. This is in the lower half of the industry: HLMN underperforms 65.63% of its industry peers.
Looking at the Return On Equity, with a value of 1.56%, HLMN is doing worse than 64.84% of the companies in the same industry.
HLMN has a Return On Invested Capital of 2.72%. This is in the lower half of the industry: HLMN underperforms 67.19% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for HLMN is significantly below the industry average of 10.69%.
The last Return On Invested Capital (2.72%) for HLMN is above the 3 year average (1.94%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.79%
ROE 1.56%
ROIC 2.72%
ROA(3y)-0.11%
ROA(5y)-0.56%
ROE(3y)-0.26%
ROE(5y)-2.17%
ROIC(3y)1.94%
ROIC(5y)1.62%
HLMN Yearly ROA, ROE, ROICHLMN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -5 -10 -15 -20

1.3 Margins

Looking at the Profit Margin, with a value of 1.24%, HLMN is doing worse than 63.28% of the companies in the same industry.
HLMN has a Operating Margin (5.91%) which is in line with its industry peers.
In the last couple of years the Operating Margin of HLMN has grown nicely.
Looking at the Gross Margin, with a value of 47.90%, HLMN belongs to the top of the industry, outperforming 90.63% of the companies in the same industry.
HLMN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 5.91%
PM (TTM) 1.24%
GM 47.9%
OM growth 3Y102.86%
OM growth 5Y36.24%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.57%
GM growth 5Y2.32%
HLMN Yearly Profit, Operating, Gross MarginsHLMN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

More info and screens

3

2. Health

2.1 Basic Checks

HLMN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, HLMN has more shares outstanding
The number of shares outstanding for HLMN has been increased compared to 5 years ago.
The debt/assets ratio for HLMN has been reduced compared to a year ago.
HLMN Yearly Shares OutstandingHLMN Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
HLMN Yearly Total Debt VS Total AssetsHLMN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

Based on the Altman-Z score of 1.61, we must say that HLMN is in the distress zone and has some risk of bankruptcy.
HLMN's Altman-Z score of 1.61 is on the low side compared to the rest of the industry. HLMN is outperformed by 75.00% of its industry peers.
HLMN has a debt to FCF ratio of 8.77. This is a slightly negative value and a sign of low solvency as HLMN would need 8.77 years to pay back of all of its debts.
HLMN has a Debt to FCF ratio (8.77) which is in line with its industry peers.
A Debt/Equity ratio of 0.60 indicates that HLMN is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.60, HLMN is doing worse than 61.72% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 8.77
Altman-Z 1.61
ROIC/WACC0.3
WACC9.18%
HLMN Yearly LT Debt VS Equity VS FCFHLMN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

HLMN has a Current Ratio of 2.46. This indicates that HLMN is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.46, HLMN is in the better half of the industry, outperforming 64.06% of the companies in the same industry.
HLMN has a Quick Ratio of 2.46. This is a bad value and indicates that HLMN is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.79, HLMN is doing worse than 75.78% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.46
Quick Ratio 0.79
HLMN Yearly Current Assets VS Current LiabilitesHLMN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 18.18% over the past year.
HLMN shows a small growth in Revenue. In the last year, the Revenue has grown by 0.31%.
HLMN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.93% yearly.
EPS 1Y (TTM)18.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)0.31%
Revenue growth 3Y1.08%
Revenue growth 5Y3.93%
Sales Q2Q%2.58%

3.2 Future

HLMN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.19% yearly.
The Revenue is expected to grow by 4.26% on average over the next years.
EPS Next Y8.13%
EPS Next 2Y2.92%
EPS Next 3Y10.75%
EPS Next 5Y14.19%
Revenue Next Year4.26%
Revenue Next 2Y5.41%
Revenue Next 3Y4.96%
Revenue Next 5Y4.26%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
HLMN Yearly Revenue VS EstimatesHLMN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B 2B 2.5B
HLMN Yearly EPS VS EstimatesHLMN Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.5 -0.5 1 -1

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 14.94 indicates a correct valuation of HLMN.
Compared to the rest of the industry, the Price/Earnings ratio of HLMN indicates a rather cheap valuation: HLMN is cheaper than 82.03% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of HLMN to the average of the S&P500 Index (27.30), we can say HLMN is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 14.11, the valuation of HLMN can be described as correct.
Based on the Price/Forward Earnings ratio, HLMN is valued a bit cheaper than 76.56% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of HLMN to the average of the S&P500 Index (21.76), we can say HLMN is valued slightly cheaper.
Industry RankSector Rank
PE 14.94
Fwd PE 14.11
HLMN Price Earnings VS Forward Price EarningsHLMN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of HLMN indicates a somewhat cheap valuation: HLMN is cheaper than 75.78% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, HLMN is valued a bit cheaper than the industry average as 68.75% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 18.51
EV/EBITDA 10.08
HLMN Per share dataHLMN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)1.84
PEG (5Y)N/A
EPS Next 2Y2.92%
EPS Next 3Y10.75%

More info and screens

0

5. Dividend

5.1 Amount

HLMN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HILLMAN SOLUTIONS CORP

NASDAQ:HLMN (7/11/2025, 8:20:47 PM)

After market: 7.77 0 (0%)

7.77

-0.18 (-2.26%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)04-29 2025-04-29/bmo
Earnings (Next)08-04 2025-08-04/bmo
Inst Owners103.41%
Inst Owner Change0.01%
Ins Owners1.12%
Ins Owner Change6.46%
Market Cap1.53B
Analysts78.57
Price Target10.93 (40.67%)
Short Float %3.07%
Short Ratio3.68
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3.25%
Min EPS beat(2)-7.7%
Max EPS beat(2)1.2%
EPS beat(4)2
Avg EPS beat(4)0.8%
Min EPS beat(4)-7.7%
Max EPS beat(4)11.6%
EPS beat(8)5
Avg EPS beat(8)8.75%
EPS beat(12)9
Avg EPS beat(12)35.03%
EPS beat(16)11
Avg EPS beat(16)166.29%
Revenue beat(2)0
Avg Revenue beat(2)-1.78%
Min Revenue beat(2)-2.16%
Max Revenue beat(2)-1.41%
Revenue beat(4)0
Avg Revenue beat(4)-1.92%
Min Revenue beat(4)-3.55%
Max Revenue beat(4)-0.57%
Revenue beat(8)0
Avg Revenue beat(8)-2.52%
Revenue beat(12)0
Avg Revenue beat(12)-2.85%
Revenue beat(16)2
Avg Revenue beat(16)-1.93%
PT rev (1m)0%
PT rev (3m)-14.77%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-12.21%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.09%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.07%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.45%
Valuation
Industry RankSector Rank
PE 14.94
Fwd PE 14.11
P/S 1.04
P/FCF 18.51
P/OCF 8.97
P/B 1.3
P/tB N/A
EV/EBITDA 10.08
EPS(TTM)0.52
EY6.69%
EPS(NY)0.55
Fwd EY7.09%
FCF(TTM)0.42
FCFY5.4%
OCF(TTM)0.87
OCFY11.14%
SpS7.5
BVpS5.98
TBVpS-1.2
PEG (NY)1.84
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.79%
ROE 1.56%
ROCE 4.18%
ROIC 2.72%
ROICexc 2.76%
ROICexgc 8.92%
OM 5.91%
PM (TTM) 1.24%
GM 47.9%
FCFM 5.59%
ROA(3y)-0.11%
ROA(5y)-0.56%
ROE(3y)-0.26%
ROE(5y)-2.17%
ROIC(3y)1.94%
ROIC(5y)1.62%
ROICexc(3y)1.97%
ROICexc(5y)1.64%
ROICexgc(3y)6.76%
ROICexgc(5y)6%
ROCE(3y)2.98%
ROCE(5y)2.49%
ROICexcg growth 3Y110.94%
ROICexcg growth 5Y37.21%
ROICexc growth 3Y112.78%
ROICexc growth 5Y43.98%
OM growth 3Y102.86%
OM growth 5Y36.24%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.57%
GM growth 5Y2.32%
F-Score7
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 8.77
Debt/EBITDA 3.23
Cap/Depr 66.13%
Cap/Sales 5.95%
Interest Coverage 1.94
Cash Conversion 77.46%
Profit Quality 449.74%
Current Ratio 2.46
Quick Ratio 0.79
Altman-Z 1.61
F-Score7
WACC9.18%
ROIC/WACC0.3
Cap/Depr(3y)59.2%
Cap/Depr(5y)51.21%
Cap/Sales(3y)4.97%
Cap/Sales(5y)4.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)18.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y8.13%
EPS Next 2Y2.92%
EPS Next 3Y10.75%
EPS Next 5Y14.19%
Revenue 1Y (TTM)0.31%
Revenue growth 3Y1.08%
Revenue growth 5Y3.93%
Sales Q2Q%2.58%
Revenue Next Year4.26%
Revenue Next 2Y5.41%
Revenue Next 3Y4.96%
Revenue Next 5Y4.26%
EBIT growth 1Y14.99%
EBIT growth 3Y105.05%
EBIT growth 5Y41.6%
EBIT Next Year150.04%
EBIT Next 3Y40.67%
EBIT Next 5Y26.22%
FCF growth 1Y5.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y10.97%
OCF growth 3YN/A
OCF growth 5Y28.46%